New Issue: JPMorgan prices $3.45 million 7.25% reverse exchangeables linked to Amgen

New York, Dec. 1 - JPMorgan Chase & Co. priced $3.45 million of 7.25% reverse exchangeable notes due Dec. 1, 2015 linked to Amgen Inc. shares, according to a 424B2 filing with the Securities and Exchange Commission.

The payout at maturity will be par in cash unless Amgen shares fall below the protection price of $121.68, 75% of the initial price of $162.24, during the life of the notes and finish below the initial price in which case the payout will be 6.1637 shares of Amgen stock.

JPMorgan is the agent.

Issuer:	JPMorgan Chase & Co.
Issue:	Reverse exchangeable notes
Underlying stock:	Amgen Inc. (Symbol: AMGN)
Amount:	$3.45 million
Maturity:	Dec. 1, 2015
Coupon:	7.25%, payable monthly
Price:	Par
Payout at maturity:	Par in cash unless Amgen shares fall below the protection price of $121.68, 75% of the initial price, and finish below the initial price, in which case 6.1637 shares of Amgen stock
Initial price:	$162.24
Protection price:	$121.68, 75% of $162.24
Exchange ratio:	6.1637
Pricing date:	Nov. 25
Settlement date:	Dec. 1
Agent:	JPMorgan
Fees:	0.25%
Cusip:	48127DY93

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.